Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Nemazee

Showing results (51-60 of 124) with videos related to

Pageof 13
Sort By:
Blood|June 28, 2019
Activated protein C ameliorates chronic graft-versus-host disease by PAR1-dependent biased cell signaling on T cellsRanjeet K Sinha, Ryan Flynn, Michael Zaiken, et al.
The Journal of Experimental Medicine|June 11, 2003
Visualization of the genesis and fate of isotype-switched B cells during a primary immune responseKathryn A Pape, Valerie Kouskoff, David Nemazee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2006
Paucity of V-D-D-J rearrangements and VH replacement events in lupus prone and nonautoimmune TdT-/- and TdT+/+ miceLisa C Watson, Chantelle S Moffatt-Blue, R Zachary McDonald, et al.
Journal of Virology|December 11, 2012
2G12-expressing B cell lines may aid in HIV carbohydrate vaccine design strategiesKatie J Doores, Michael Huber, Khoa M Le, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 14, 2013
B cells from knock-in mice expressing broadly neutralizing HIV antibody b12 carry an innocuous B cell receptor responsive to HIV vaccine candidatesTakayuki Ota, Colleen Doyle-Cooper, Anthony B Cooper, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 14, 2013
Immune tolerance negatively regulates B cells in knock-in mice expressing broadly neutralizing HIV antibody 4E10Colleen Doyle-Cooper, Krystalyn E Hudson, Anthony B Cooper, et al.
The Journal of Experimental Medicine|December 30, 2009
Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivoBao Hoa Duong, Hua Tian, Takayuki Ota, et al.
Clinical Chemistry|October 21, 2020
Commercial Serology Assays Predict Neutralization Activity against SARS-CoV-2Raymond T Suhandynata, Melissa A Hoffman, Deli Huang, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune ResponsesRaymond T Suhandynata, Nicholas J Bevins, Jenny T Tran, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2020
A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibodyNicholas C Wu, Meng Yuan, Sandhya Bangaru, et al.
Pageof 13

Showing results (51-60 of 124) with videos related to

Sort By:
Pageof 13
Blood|June 28, 2019
Activated protein C ameliorates chronic graft-versus-host disease by PAR1-dependent biased cell signaling on T cellsRanjeet K Sinha, Ryan Flynn, Michael Zaiken, et al.
The Journal of Experimental Medicine|June 11, 2003
Visualization of the genesis and fate of isotype-switched B cells during a primary immune responseKathryn A Pape, Valerie Kouskoff, David Nemazee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2006
Paucity of V-D-D-J rearrangements and VH replacement events in lupus prone and nonautoimmune TdT-/- and TdT+/+ miceLisa C Watson, Chantelle S Moffatt-Blue, R Zachary McDonald, et al.
Journal of Virology|December 11, 2012
2G12-expressing B cell lines may aid in HIV carbohydrate vaccine design strategiesKatie J Doores, Michael Huber, Khoa M Le, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 14, 2013
B cells from knock-in mice expressing broadly neutralizing HIV antibody b12 carry an innocuous B cell receptor responsive to HIV vaccine candidatesTakayuki Ota, Colleen Doyle-Cooper, Anthony B Cooper, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 14, 2013
Immune tolerance negatively regulates B cells in knock-in mice expressing broadly neutralizing HIV antibody 4E10Colleen Doyle-Cooper, Krystalyn E Hudson, Anthony B Cooper, et al.
The Journal of Experimental Medicine|December 30, 2009
Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivoBao Hoa Duong, Hua Tian, Takayuki Ota, et al.
Clinical Chemistry|October 21, 2020
Commercial Serology Assays Predict Neutralization Activity against SARS-CoV-2Raymond T Suhandynata, Melissa A Hoffman, Deli Huang, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune ResponsesRaymond T Suhandynata, Nicholas J Bevins, Jenny T Tran, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2020
A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibodyNicholas C Wu, Meng Yuan, Sandhya Bangaru, et al.
Pageof 13